Exome sequencing targets only the protein coding regions of the genome.  The exome is estimated to cover only 1% of the genome; however, 85% of all the disease-causing mutations are believed to be in the exome.  PrimBio helps researchers and clinicians to identify SNPs and indels in the genes implicated in over 6,800 rare diseases using exome sequencing.  We offer Ampliseq Exome sequencing using patented Ampliseq technology.  Ampliseq Exome sequencing covers >19,000 coding genes and >198,000 coding exons.  In 2013, PrimBio was selected by Life Technologies as a certified ​Ampliseq Exome Service Provider.  We are one of a few companies or institutions to have been selected worldwide.  This certification validates that our services are of the highest quality and that customers can highly rely on those services.  We also offer whole exome sequencing for human and mouse DNA samples.  All Ampliseq Exome and whole exome sequencing services include library preparation, sequencing, alignment and variant calling.  In-depth bioinformatics is available upon request.